Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin in Leber's Hereditary Optic Neuropathy
NCT00528151Phase 3Completed
- Sponsor
- Mahidol University
- Start
- May 2005
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of curcumin in Leber hereditary optic neuropathy (LHON), sponsored by Mahidol University. Started May 2005; status: completed.
02
Drugs
curcumin
03
Conditions
Leber hereditary optic neuropathy (LHON)
Beyond the preview
Go deeper on NCT00528151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528151.